MEETINGS - International conference on Nasal Drug Delivery (UK) March 2002:
This article was originally published in Clinica
The fifth international conference on Nasal Drug Delivery will be held on March 21-22 2002 at Le Meridien Hotel, London, UK. Leading authorities in the field will address many aspects including basic physiology, safety and compliance issues, latest developments and market predictions. Further details from Management Forum on tel: +44 (0)1483 570099; fax: +44 (0)1483 536424; email: management-forum.co.uk www.management-forum.co.uk
You may also be interested in...
Data show Opdivo/Cabometyx combo bests Sutent for overall and progression-free survival and response endpoints in first-line RCC. Exelixis CEO says comparison to Sutent is standard control and allows better comparison to other combo regimens.
ES: Public Company Edition: Fifty biopharma companies launched initial public offerings in the US last year and there have been 52 so far in 2020, including Metacrine, Dyne, Athira and COMPASS.
In an update to stakeholders, the US FDA says regulators can successfully evaluate a firm’s performance, allowing it to eventually get medical software to market in the agency’s Pre-Cert Program.